Literature DB >> 26256456

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee.

Michael R Jaff1, Christopher J White2, William R Hiatt3, Gerry R Fowkes4, John Dormandy5, Mahmood Razavi6, Jim Reekers7, Lars Norgren8.   

Abstract

The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) guidelines were last updated in 2007 (TASC II) and represented the collaboration of international vascular specialties involved in the management of patients with peripheral arterial disease (PAD). Since the publication of TASC II, there have been innovations in endovascular revascularization strategies for patients with PAD. The intent of this publication is to provide a complete anatomic lower limb TASC lesion classification, including the infrapopliteal segment, and an updated literature review of new endovascular techniques and practice patterns employed by vascular specialists today.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  angioplasty; arteries; claudication; critical limb ischemia; occlusion; peripheral artery disease; revascularization; stenosis; stents; surgery

Mesh:

Year:  2015        PMID: 26256456     DOI: 10.1002/ccd.26122

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  11 in total

1.  Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery.

Authors:  Nathan K Itoga; Tanner Kim; Anna M Sailer; Dominik Fleischmann; Matthew W Mell
Journal:  J Vasc Surg       Date:  2017-05-11       Impact factor: 4.268

2.  SCAI guidelines on device selection in Aorto-Iliac arterial interventions.

Authors:  Dmitriy N Feldman; Ehrin J Armstrong; Herbert D Aronow; Subhash Banerjee; Larry J Díaz-Sandoval; Michael R Jaff; Sasanka Jayasuriya; Safi U Khan; Andrew J Klein; Sahil A Parikh; Kenneth Rosenfield; Mehdi H Shishehbor; Rajesh V Swaminathan; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-14       Impact factor: 2.692

Review 3.  Team-Based Care in Patients with Chronic Limb-Threatening Ischemia.

Authors:  Yulanka Castro-Dominguez; Mehdi H Shishehbor
Journal:  Curr Cardiol Rep       Date:  2022-02-07       Impact factor: 2.931

Review 4.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

5.  Is Endothelial Dysfunction a Therapeutic Target for Peripheral Artery Disease?: PRDM16 is going out on a limb.

Authors:  Sandeep Kumar; Aitor Andueza; Hanjoong Jo
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

6.  Therapeutic Angiogenesis with Sound Waves.

Authors:  Tomohiko Shindo; Hiroaki Shimokawa
Journal:  Ann Vasc Dis       Date:  2020-06-25

7.  The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review.

Authors:  A Mizzi; K Cassar; C Bowen; C Formosa
Journal:  J Foot Ankle Res       Date:  2019-08-06       Impact factor: 2.303

8.  The triglyceride-glucose index predicts peripheral artery disease complexity

Authors:  Bilge Duran Karaduman; Hüseyin Ayhan; Telat Keleş; Engin Bozkurt
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

9.  Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study.

Authors:  Tianyue Pan; Xiaolang Jiang; Hao Liu; Yifan Liu; Weiguo Fu; Zhihui Dong
Journal:  Front Cardiovasc Med       Date:  2022-02-09

10.  Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells.

Authors:  Ting-Hsing Chao; I-Chih Chen; Yi-Heng Li; Po-Tseng Lee; Shih-Ya Tseng
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.